Hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A multicenter propensity score-matched cohort study

OBJECTIVE: Systemic chemotherapy has limited efficacy in the treatment of peritoneal metastasis (PM) in gastric cancer (GC). Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with complete cytoreductive surgery (CRS) has shown promising outcomes but remains controversial. The present study...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Ziying, Wang, Jiahong, Li, Zhi, Li, Baozhong, Luo, Jiali, Wang, Xuejun, Wang, Jin, Ba, Mingchen, Tang, Hongsheng, He, Qingjun, Liao, Quanxing, Yang, Xiansheng, Guan, Tianpei, Liang, Han, Cui, Shuzhong, on behalf of the Chinese Peritoneal Oncology Study Group
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797229/
https://www.ncbi.nlm.nih.gov/pubmed/33447001
http://dx.doi.org/10.21147/j.issn.1000-9604.2020.06.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797229/
https://www.ncbi.nlm.nih.gov/pubmed/33447001
http://dx.doi.org/10.21147/j.issn.1000-9604.2020.06.12

Ejemplares similares